New York City Eye Study (NYCES) (NYCES)
Glaucoma, Vision Impairment and Blindness, Cataract
About this trial
This is an interventional other trial for Glaucoma
Eligibility Criteria
Inclusion Criteria: Individuals age 21 and older. Living independently in an affordable housing development and surrounding neighborhoods. Exclusion Criteria: Self-reported terminal illness with life expectancy less than 1 year. Inability to provide informed consent due to dementia or other reasons.
Sites / Locations
- Columbia University Irving Medical Center - 622 W. 168th St. Floor 18
Arms of the Study
Arm 1
Arm 2
Active Comparator
Placebo Comparator
Arm 1: Intervention Using Patient Navigators
Arm 2: Usual Care Without Patient Navigators
Consented participants referred to ophthalmology from the 9 developments randomized to the Intervention Arm will receive ongoing support from patient navigators to assist with all aspects of follow-up eye care and ocular surgery at either Harkness Eye Institute or Harlem Hospital, specifically eye exam appointment scheduling and arranging transportation over a 1-year period.
Consented participants referred from the 5 developments randomized to the Usual Care Arm 2 who are referred to an ophthalmologist for a follow-up eye exam will only be scheduled for their initial appointment at either Harkness Eye Institute or Harlem Hospital. They will not receive enhanced support. Scheduling this initial appointment will allow tracking of adherence. Arm 2 represents a realistic choice available for participants following screening over a 1-year period.